CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 357

Industry reads hand-picked by our editors

Oct 01, 2015

Bloomberg
Teva to buy Mexican drug maker Rimsa for about $2.3B
Pharma Times
Merck sells Kuvan rights back to BioMarin
Pharmalot
Physician group questions FDA view on testosterone drugs

Sep 30, 2015

Pharmalot
FDA's Woodcock explains agency's plan to reduce drug shortages
Nature
Gene-edited 'micropigs' to be sold as pets at Chinese institute
Reuters
Israel's MediWound signs $112M deal in U.S. for burn treatment

Sep 29, 2015

Reuters
U.S. 'right to try' laws may not help dying get unapproved drugs
FierceBiotech
Esperion tanks after inviting Wall Street to parse its regulatory future
in-PharmaTechnologist
Heptares awarded NIH grant to tackle cocaine addiction

Sep 28, 2015

Huffington Post
Part 14 of Brill's Risperdal exposé: J&J on the witness stand
The New Republic
The Wonder Drug: Inside the medical marijuana industry's wild new frontier
MobiHealthNews
Teva snaps up 'smart inhaler' company Gecko Health

Sep 25, 2015

Reuters
Novartis' new heart drug on track for approval in Europe
Pharma Times
Shire victorious in US Vyvanse patent battle
FiercePharma
Alexion sues Canada over Soliris price cut attempt

Sep 24, 2015

Reuters
Nobel Prize predictions see honors for gene editing technology
Bloomberg
Clinton's `Price Gouging' Tweet Sends Drugmaker Hedges Surging
Biz Journals
How just $150K could shape the future of Alzheimer's drug development

Sep 23, 2015

Reuters
OncoGenex's pancreatic cancer drug found ineffective in study
WSJ
Goldman’s Lloyd Blankfein: How to Understand a Lymphoma Diagnosis
FierceBiotech
Otsuka wins early FDA approval for a colorectal cancer combo drug

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Webinar - on demand
Navigating the Impact of Claims Data Volatility on Biopharma Custom content for McKesson Compile
Infographic
Cutting Through the Chaos of Safety Letter Distribution Custom content for WCG
Playbook
How To Make the Most of Your Life Science Webinars Custom content for Cvent

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

AI-Powered Biomarker Discovery: From Screening to Translational Insights Webinar - on demand • Provided by Danaher
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Revolutionizing Next Generation Gene Therapies with On-Demand Large DNA Construct Synthesis and Novel, Designable Delivery Vehicles Webinar - on demand • Provided by Ansa Biotechnologies

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.